West Pharmaceutical Services WST Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $542.7M+16.2% | $493.7M+0.2% | $491.7M-1.6% | $487.7M-7.1% | $467.2M-17.8% | ||
| $174.1M+11.5% | $168.6M+11.1% | $162M+10.5% | $159M+11.9% | $156.2M+13.4% | ||
| $29.1M+94.0% | $23.8M+27.3% | $21.4M+35.4% | $18.1M+9.0% | $15M-24.2% | ||
| $715.3M+7.6% | $754.8M+15.5% | $693.8M-1.2% | $676.7M-10.1% | $664.6M-12.2% | ||
| $257.3M-28.1% | $285.9M-24.2% | $314.7M-17.4% | $332.7M-15.8% | $357.7M-3.5% | ||
| -$257.3M+28.4% | -$285.9M+24.5% | -$314.6M+17.8% | -$333.4M+15.9% | -$359.4M+4.7% | ||
| $61.8M+3.7% | $61.2M+3.6% | $60.7M+3.6% | $60.1M+3.4% | $59.6M+3.5% | ||
| —— | —— | —— | $240.8M-63.5% | $427.4M-33.8% | ||
| -$346.8M+30.4% | -$185.1M+70.3% | -$242.3M+67.4% | -$295.2M+57.9% | -$498.6M+24.4% | ||
| $117.2M— | $306.7M— | $137.6M— | —— | —— | ||
| $458M+49.2% | $468.9M+69.6% | $379.1M+17.9% | $344M-3.7% | $306.9M-20.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does West Pharmaceutical Services generate?
- West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
- What is West Pharmaceutical Services's free cash flow?
- After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
- Where does West Pharmaceutical Services's cash flow data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
